EU Approves Certolizumab Pegol for Pregnant & Nursing Patients
Should Patients with Rheumatic Disease Switch from Biologic to Biosimilar?
Biosimilars: Still Waiting for Promise to Materialize
Bimekizumab Improves Joint & Skin Symptoms in PsA Patients
Biosimilar SB2 May Work as Well as Infliximab for Rheumatoid Arthritis
Etanercept’s New Autoinjection System; Plus FDA Approves Ixekizumab for Active PsA
E6011 Safe & Well Tolerated in RA Patients
Pfizer’s Second Biosimilar of J&J’s Remicade Wins U.S. FDA Approval
Upadacitinib Promising for RA in Phase 3 Study
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 27
- Next Page »